Skip to main content
Cancers logoLink to Cancers
. 2020 May 26;12(6):1359. doi: 10.3390/cancers12061359

Correction: Oh, J.Y., et al. Synergistic Autophagy Effect of miR-212-3p in Zoledronic Acid-Treated In Vitro and Orthotopic In Vivo Models and in Patient-Derived Osteosarcoma Cells, Cancers 2019, 11, 1812

Ju Yeon Oh 1,2,, Eun Ho Kim 3,, Yeon-Joo Lee 4, Sei Sai 5, Sun Ha Lim 3, Jang Woo Park 6, Hye Kyung Chung 6, Joon Kim 1, Guillaume Vares 7, Akihisa Takahashi 8, Youn Kyoung Jeong 9, Mi-Sook Kim 10,*, Chang-Bae Kong 11,*
PMCID: PMC7352918  PMID: 32466571

The authors wish to make the following corrections to this paper [1]:

The authors would like to replace Figure 3b in [1]. The correction is to correct errors in the arrangement of the Western blots. The original version of Figure 3b is:

graphic file with name cancers-12-01359-i001.jpg

and should be replaced with the following Figure 3b:

graphic file with name cancers-12-01359-i002.jpg

The authors would like to replace the first affiliation in [1]. The original affiliation is “Laboratory of Biochemistry, School of Life Sciences and Biotechnology, Korea University, Seongbuk-gu, Seoul 136-701, Korea” and should be replaced with “Laboratory of Biochemistry, Division of Life Sciences, Korea University, Seongbuk-gu, Seoul 02841, Korea”.

The authors would like to apologize for any inconvenience caused to the readers by these changes.

References

  • 1.Oh J.Y., Kim E.H., Lee Y.J., Sai S., Lim S.H., Park J.W., Chung H.K., Kim J., Vares G., Takahashi A., et al. Synergistic Autophagy Effect of miR-212-3p in Zoledronic Acid-Treated In Vitro and Orthotopic In Vivo Models and in Patient-Derived Osteosarcoma Cells. Cancers. 2019;11:1812. doi: 10.3390/cancers11111812. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Cancers are provided here courtesy of Multidisciplinary Digital Publishing Institute (MDPI)

RESOURCES